Immunic IMUX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 11.1 | 101.99 | -1.08 | -33,235 | -33 | |
| 2025Q4 | 5.34 | 120.87 | -0.7 | -23,327 | -19 | |
| 2025Q3 | 8.82 | 101.62 | -1 | -25,993 | -26 | |
| 2025Q2 | 6.98 | 100.98 | -1.99 | -27,083 | -27 | |
| 2025Q1 | 10.9 | 105.31 | -2.51 | -26,825 | -25 | |
| 2024Q4 | 10 | 101.81 | -2.5 | -25,631 | -25 | |
| 2024Q3 | 16.5 | 105.57 | -2.4 | -25,726 | -24 | |
| 2024Q2 | 11.1 | 106.71 | -2.1 | -22,814 | -21 | |
| 2024Q1 | 13.2 | 80.72 | -3 | -23,881 | -30 | |
| 2023Q4 | 15 | 108.39 | -4.8 | -23,381 | -22 | |
| 2023Q3 | 14.7 | 103.52 | -5.1 | -23,570 | -23 | |
| 2023Q2 | 25.1 | 104.26 | -5.4 | -25,021 | -24 | |
| 2023Q1 | 14.9 | 107.83 | -5.8 | -27,251 | -25 | |
| 2022Q4 | 14 | 101.51 | -16.2 | -57,327 | -56 | |
| 2022Q3 | 31.6 | 94.78 | -6.7 | -20,116 | -21 | |
| 2022Q2 | 34.7 | 94.11 | -7.5 | -20,610 | -22 | |
| 2022Q1 | 113 | 103.01 | -7.4 | -21,435 | -21 | |
| 2021Q4 | 95.7 | 102.53 | -6 | -21,721 | -21 | |
| 2021Q3 | 88.5 | 95.31 | -8.9 | -18,387 | -19 | |
| 2021Q2 | 122.6 | 106.89 | -8.1 | -19,170 | -18 |